• Profile
Close

Growth, bone health & ambulatory status of boys with DMD treated with daily vs intermittent oral glucocorticoid regimen

Bone Jul 28, 2018

Crabtree NJ, et al. - In this pragmatic longitudinal study authors compared growth, body mass, bone mineral density (BMD), vertebral fractures (VF) and ambulatory status in boys with Duchenne muscular dystrophy (DMD) between daily or intermittent oral glucocorticoids (GC) regimens. At the cost of more vertebral fractures, greater adiposity and markedly diminished growth, more boys on daily GCs were seen to remain ambulant. On the contrary, fewer vertebral fractures were seen in boys on intermittent GCs, however, more boys lost independent ambulation.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay